Tanvex BioPharma Inc (6541) — Financial Flexibility Index
Tanvex BioPharma Inc (6541) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of NT$-133.84 Million (operating CF NT$-309.37 Million minus capex NT$175.53 Million) represents 0% of total liabilities (NT$2.27 Billion). Check Tanvex BioPharma Inc (6541) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tanvex BioPharma Inc Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Tanvex BioPharma Inc across 13 annual periods. For the full cash flow conversion analysis, see Tanvex BioPharma Inc operating cash flow efficiency.
Annual Financial Flexibility Index for Tanvex BioPharma Inc (2013–2025)
Year-by-year free cash flow to debt coverage for Tanvex BioPharma Inc. Explore how well can Tanvex BioPharma Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.15x | NT$-335.24 Million | NT$-1.01 Billion | NT$2.27 Billion | ▲ +73.8% |
| 2024 | -0.56x | NT$-1.04 Billion | NT$-1.15 Billion | NT$1.84 Billion | ▲ +19.5% |
| 2023 | -0.70x | NT$-1.36 Billion | NT$-1.43 Billion | NT$1.94 Billion | ▼ -15.0% |
| 2022 | -0.61x | NT$-1.24 Billion | NT$-1.33 Billion | NT$2.03 Billion | ▲ +13.7% |
| 2021 | -0.71x | NT$-1.36 Billion | NT$-1.39 Billion | NT$1.92 Billion | ▲ +28.0% |
| 2020 | -0.98x | NT$-1.72 Billion | NT$-1.79 Billion | NT$1.75 Billion | ▲ +70.5% |
| 2019 | -3.33x | NT$-1.81 Billion | NT$-1.90 Billion | NT$542.12 Million | ▲ +41.3% |
| 2018 | -5.67x | NT$-1.50 Billion | NT$-1.61 Billion | NT$263.92 Million | ▼ -15.9% |
| 2017 | -4.90x | NT$-1.10 Billion | NT$-1.21 Billion | NT$223.78 Million | ▼ -150.5% |
| 2016 | -1.95x | NT$-584.86 Million | NT$-833.43 Million | NT$299.25 Million | ▲ +23.6% |
| 2015 | -2.56x | NT$-310.73 Million | NT$-684.20 Million | NT$121.41 Million | ▲ +40.1% |
| 2014 | -4.27x | NT$-278.11 Million | NT$-434.17 Million | NT$65.09 Million | ▼ -85.7% |
| 2013 | -2.30x | NT$-192.38 Million | NT$-239.86 Million | NT$83.63 Million | — |